Skip to content

Author

Sara Zannone

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Harms associated with engaging with AI for mental health support: A scoping review protocol

Background Artificial intelligence (AI) is increasingly used for mental health support, through both purpose-built products and general-purpose large language models (LLMs), at a pace far greater than evidence of their efficacy or safety. There is no consensus taxonomy of the potential harms arising from this use, and existing classification frameworks are fragmented across clinical, computational, ethical, and regulatory domains. Objective This scoping review aims to systematically map the harms which may arise from engaging with AI for mental health support, as formulated in the academic literature, regulatory frameworks, grey literature, and practitioner guidance, to inform the co-production of a harm taxonomy. Methods We will follow the framework of Arksey and O’Malley, as refined by Levac et al. and the Joanna Briggs Institute, with reporting adhering to the PRISMA Extension for Scoping Reviews (PRISMA-ScR). We will search MEDLINE (Ovid), Embase (Ovid), APA PsycINFO (EBSCOhost), Scopus, Web of Science, ACM Digital Library, IEEE Xplore, ProQuest Dissertations and Theses Global, PROSPERO, and Google Scholar for peer-reviewed literature and preprints, combining terms for AI technologies, mental health, and harm. Grey literature searches will cover regulatory bodies, professional associations, the Mental Health Innovation Network, OpenSyllabus, and preprint repositories. No date restriction will be applied; searches will be restricted to English. Titles, abstracts, and full texts will be screened independently by two reviewers following a calibration exercise. Data will be charted using a piloted standardised instrument and synthesised narratively through descriptive tabulation and iterative harm mapping, with consultation of lived experience advisors and clinical experts before finalisation. Ethics and dissemination No primary data will be collected, so ethical approval is not required. Findings will be published as a peer-reviewed manuscript, presented at conferences, and used to inform co-production workshops within the SAFER-MH programme.

X. Hunt, A. G. Mokaya, Sara Zannone et al. · 0 citations
Preprint Jul 2026

Alignment Plausibility: A New Standard for Assuring AI in Healthcare

Large language models (LLMs) have become significant providers of mental health support, yet they remain products of an attention economy whose operational and commercial targets favour sustained engagement over the friction that effective psychological support often requires. Developers'safety responses have been largely reactive, addressing the most visible and acute harms while subtler, longer-term patterns of risk (e.g., dependency, boundary erosion, the amplification of distorted beliefs) receive less attention. We contend that making LLMs structurally safe requires alignment organised at three levels that mirror how society assures the safety of human clinical practice: 1) explicit value specification grounded in the codified normative commitments of clinical practice; 2) training that embeds those values in the model; and 3) oversight that detects drift and longer-term harm during deployment, much as clinical supervision does for human practice. Organising alignment in this way yields a construct we call alignment plausibility - a structured demonstration that a system's values, training regime, and oversight mechanisms are together consistent with safe and positive outcomes. We propose alignment plausibility as a regulatory construct (by drawing analogy to the established construct of biological plausibility) for AI in health: a principled way to argue for, or against, trust that systems are aligned to positive health outcomes, will cause no harm even where capable of doing so, and will ultimately lead to patient benefit.

G. Williams, Sara Zannone, B. Mateen · 0 citations